BLCO

Bausch + Lomb Corporation

63
Fundamentals69/ 100
Valuation50/ 100
Upside potential57/ 100
Risk potential17/ 100

BLCO lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.

BLCO Fundamentals

MetricStatus
Stable
Stable
Healthy
Weak

BLCO's cash flow is currently healthy, and its revenue and profitability are stable, but its balance sheet is weak.

BLCO PE Valuation

BLCO has no meaningful PE right now: it lost money over the past year.

BLCO Forward outlook

MetricOutlook
--
Strong growth
Growth
Strongly improving
Limited
Low

Analysts expect earnings and revenue growth for BLCO, with profitability improving. However, they disagree widely on these estimates.

BLCO Risk to reward

ScenarioChangePrice
Upside+22%$25.86
Downside-17%$17.52

Calculated from the latest close: $21.14 on Nov 12.

BLCO's one-year upside scenario is somewhat larger than its downside: +22% against −17%.

BLCO Earnings Per Share

Q4 2023: $-0.74Q1 2024: $-0.96Q2 2024: $-1.30Q3 2024: $-1.05Q4 2024: $-0.90Q1 2025: $-1.02Q2 2025: $-0.77Q3 2025: $-0.86Q4 2025: $-1.02Q1 2026: $-0.62Q2 2026: $-0.48Q3 2026: $-0.31Forward: $1.17
Q4 2023: $-0.74Q1 2024: $-0.96Q2 2024: $-1.30Q3 2024: $-1.05Q4 2024: $-0.90Q1 2025: $-1.02Q2 2025: $-0.77Q3 2025: $-0.86Q4 2025: $-1.02Q1 2026: $-0.62Q2 2026: $-0.48Q3 2026: $-0.31Forward: $1.17
QuarterTTM EPSYoY
Forward$1.17—
Q3 2026-$0.31+$0.55
Q2 2026-$0.48+$0.29
Q1 2026-$0.62+$0.40
Q4 2025-$1.02-$0.12
Q3 2025-$0.86+$0.19
Q2 2025-$0.77+$0.53
Q1 2025-$1.02-$0.06
Q4 2024-$0.90-$0.16

BLCO is still losing money, but far less than before: $0.31 per share over the past year, against $1.30 at its worst in mid-2024.

BLCO Quarterly Revenue

Q4 2023: $1.2BQ1 2024: $1.1BQ2 2024: $1.2BQ3 2024: $1.2BQ4 2024: $1.3BQ1 2025: $1.1BQ2 2025: $1.3BQ3 2025: $1.3BQ4 2025: $1.4BQ1 2026: $1.2BQ2 2026: $1.4BQ3 2026: $1.4B
Q4 2023: $1.2BQ1 2024: $1.1BQ2 2024: $1.2BQ3 2024: $1.2BQ4 2024: $1.3BQ1 2025: $1.1BQ2 2025: $1.3BQ3 2025: $1.3BQ4 2025: $1.4BQ1 2026: $1.2BQ2 2026: $1.4BQ3 2026: $1.4B
QuarterRevenueYoY
Q3 2026$1.4B+7.3%
Q2 2026$1.4B+9.1%
Q1 2026$1.2B+9.4%
Q4 2025$1.4B+9.8%
Q3 2025$1.3B+7.1%
Q2 2025$1.3B+5.1%
Q1 2025$1.1B+3.5%
Q4 2024$1.3B+9.1%

BLCO's revenue has grown year over year for 15 quarters in a row: $1.4B last quarter, up 7.3% from the same quarter a year ago.

BLCO Free Cash Flow

Q4 2023: −$69MQ1 2024: −$26MQ2 2024: −$57MQ3 2024: $94MQ4 2024: −$70MQ1 2025: −$135MQ2 2025: −$54MQ3 2025: $63MQ4 2025: $60MQ1 2026: −$68MQ2 2026: $82MQ3 2026: $178M
Q4 2023: −$69MQ1 2024: −$26MQ2 2024: −$57MQ3 2024: $94MQ4 2024: −$70MQ1 2025: −$135MQ2 2025: −$54MQ3 2025: $63MQ4 2025: $60MQ1 2026: −$68MQ2 2026: $82MQ3 2026: $178M
QuarterFree cash flowYoY
Q3 2026$178M+183%
Q2 2026$82M+$136M
Q1 2026-$68M+$67M
Q4 2025$60M+$130M
Q3 2025$63M-33%
Q2 2025-$54M+$3M
Q1 2025-$135M-$109M
Q4 2024-$70M-$1M

BLCO's free cash flow has turned positive after four years mostly in the red: $252M over the past year.

BLCO Total Shares

Q4 2023: 351MQ1 2024: 351MQ2 2024: 352MQ3 2024: 354MQ4 2024: 352MQ1 2025: 353MQ2 2025: 354MQ3 2025: 354MQ4 2025: 354MQ1 2026: 355MQ2 2026: 357MQ3 2026: 362M
Q4 2023: 351MQ1 2024: 351MQ2 2024: 352MQ3 2024: 354MQ4 2024: 352MQ1 2025: 353MQ2 2025: 354MQ3 2025: 354MQ4 2025: 354MQ1 2026: 355MQ2 2026: 357MQ3 2026: 362M
PeriodChange %Net change
Quarterly+1.2%+4.4M shares
1 year+2.1%+7.3M shares
3 years+3.1%+10.7M shares
5 years+3.3%+11.5M shares
Available history+3.3%+11.5M shares

BLCO has 362M diluted shares, up 2.1% from a year ago.

BLCO Net Leverage

Q4 2023: 8.3xQ1 2024: 7.9xQ2 2024: 8.1xQ3 2024: 7.5xQ4 2024: 7.5xQ1 2025: 9.2xQ2 2025: 10.1xQ3 2025: 9.0xQ4 2025: 8.7xQ1 2026: 7.4xQ2 2026: 6.4xQ3 2026: 5.7x
Q4 2023: 8.3xQ1 2024: 7.9xQ2 2024: 8.1xQ3 2024: 7.5xQ4 2024: 7.5xQ1 2025: 9.2xQ2 2025: 10.1xQ3 2025: 9.0xQ4 2025: 8.7xQ1 2026: 7.4xQ2 2026: 6.4xQ3 2026: 5.7x
QuarterNet LeverageStatus
Q3 20265.7xHigh
Q2 20266.4xHigh
Q1 20267.4xHigh
Q4 20258.7xHigh
Q3 20259.0xHigh
Q2 202510.1xHigh
Q1 20259.2xHigh
Q4 20247.5xHigh

BLCO's net debt is about 5.7 years of its operating earnings (EBITDA), down from 9.0 years a year ago.

BLCO Weekly Momentum

MetricValueStatus
RSI73.1Overbought
Stochastic83.1Overbought

BLCO's weekly RSI is 73 (overbought) and its Stochastic is 83 (overbought).

BLCO PE vs Healthcare Sector

MetricBLCOSector medianRelative
PEN/A26x—

BLCO has no meaningful PE right now: it lost money over the past year.

BLCO Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$18.316% above
20 week MA$17.521% above
50 week MA$16.925% above
100 week MA$15.734% above
200 week MA$16.429% above

BLCO has climbed back above all five of its weekly moving averages, and it's now 29% above its 200-week average.

BLCO Yearly ROI

YearStart priceEnd priceROI
2022$20.0$14.6-27%
2023$14.6$17.1+17%
2024$17.1$18.0+5.3%
2025$18.0$17.2-4.4%
2026 YTD$17.2$21.1+23%

BLCO has finished lower in two of the last four years. It's up 23% so far in 2026.

Give your agent the market.

Get API key